UnknownNot Applicable

Enhanced Recovery After Surgery (ERAS) in Patients Undergoing Emergency Laparotomy

China160 participantsStarted 2023-11-01

Plain-language summary

The goal of this clinical trial is to test the safety and effectiveness of the ERAS protocols compared to a conventional care protocols in patients who received emergency laparotomy. The main question it aims to answer are: • Can the ERAS protocols be used safely and effectively in patients undergoing emergency laparotomy? Participants will be randomised into the ERAS group and the conventional group and will be given the ERAS protocols and the conventional protocols in the perioperative period. Researchers will compare the ERAS group with the conventional group to see if the ERAS programme is effective.

Who can participate

Age range

18 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients between the ages 18-70, * Patients who completed the preoperative examination and preoperative diagnosis within 4 hours after admission for acute abdomen diseases, * Required emergency surgery within 6 hours from surgeon encounter. Exclusion Criteria: * Patients who refused to be enrolled in this study; * Patients with any psychiatric or neurological disorders; * Pseptic shock at admission; * Duration of symptoms more than five days; * Patients with contraindications to the placement of lumbar epidural catheters, such as coagulation disorders, severe sepsis, etc.; * Presence of preoperative factors affecting wound healing (e.g. long-term steroid use); * Patients with extra-abdominal injuries or terminal malignancy, or patients requiring damage control surgery; * Patients found intraoperatively to require any procedure other than splenectomy, partial hepatectomy or liver repair, bowel resection and anastomosis, laparoscopic cholecystectomy and appendectomy, and gastrointestinal perforation repair.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

postoperative recovery time

Timeframe: From enrollment to the end of treatment at 2 weeks

Trial details

NCT IDNCT06182488

SponsorTianjin Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11-30

Contact for this trial

Jianing Lu, MD

86-022-60910136 lujianing2006@163.com

View on ClinicalTrials.gov More Acute Abdomen trials